B.Sc. & Ph.D Neurophysiology
Based in Germany, Jon's main activities at XL TechGroup comprise the identification, evaluation and acquisition of novel technologies for the generation of new companies in the XL TechGroup pipeline, as well as management responsibilities which are currently focused on QuoNova.
Jon brings over twenty years' senior management experience at some of the leading pharmaceutical companies in the world. His industrial career began at Schering AG where, as Departmental Head CNS Research, he had responsibility for major collaborative and internal drug discovery efforts in Parkinson's disease and Alzheimer's disease. He moved to business development as Global Director, Discovery Alliances at AstraZeneca PLC, focusing on respiratory and inflammatory diseases and most recently was Corporate Head, Business Development at Boehringer Ingelheim, with responsibility for product acquisitions in the clinical phase across all major indications.
Jon has a Bachelor of Science degree and a Ph.D in Neurophysiology from the University of St Andrews, Scotland.